Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2024)

LAURUS SYNTHESIS PRIVATE LIMITED
• Providing end-to-end CDMO Services to Pharma (Human and Animal Health) and Crop Protection Industries
• Drug Substance Development in our R&D facility with more than 1000 scientists. Supported by latest lab scale process equipment and analytical instruments
• Drug Product Development integrating...
View profile

Featured Speaker (BOS Manchester 2024)

An Integrated CMC Approach to Expedite Early Phase Drug Product Development

Dr Ziheng (Harry) Wang, Senior Director-DP Early Phase Development, WuXi STA

ABSTRACT: Pharmaceutical innovation continues to be prolific, with more and more new drug candidates entering clinical trials. Speed to the clinic and conducting efficacy studies are critical and can influence the success of new molecules during early-phase drug product development. CMC activities often pose bottlenecks to IND filing if they aren’t part of a larger strategy. Implementing an integrated CMC strategy can mitigate these challenges, streamline development timelines, and enhance success rates at the early stage.

In this presentation, we will explore WuXi STA's comprehensive "end-to-end"... Click here to Read More